Research Article
CX3CR1 at V249M and T280M Gene Polymorphism and Its Potential Risk for End-Stage Renal Diseases in Egyptian Patients
Table 1
Comparison of demographic and laboratory data between patients and control group.
| | | ESRD (n = 100) | Healthy control (n = 100) | |
| | Age (mean ± SD) | 51.02 ± 7.8 | 50.1 ± 6.6 | = 0.4 | Gender
Male n (%)
Female n (%) | 61 [61%]
39 [39%] | 49 [49%]
51 [51%] | = 0.1 | | Hemoglobin gm/dl (mean ± SD) | 10.8 ± 1.4 | 13.2 ± 1.7 | = 0.002 | | Total leucocytes × 103/cmm (mean ± SD) | 7.4 ± 5.3 | 7.6 ± 2.3 | = 0.7 | | Platelets × 103/cmm (mean ± SD) | 185.5 ± 78.9 | 216.1 ± 69.4 | = 0.004 | | Creatinine mg/dl (mean ± SD) | 10.4 ± 1.04 | 1.0 ± 0.25 | = 0.0001 | | Urea mg/dl (mean ± SD) | 121.5 ± 112.2 | 27.01 ± 2.6 | = 0.0001 | | Calcium mg/l (mean ± SD) | 8.2 ± 0.7 | 9.6 ± 0.5 | = 0.0001 | | Cholesterol mg/dl | 211.9 ± 51.5 | 207.8 ± 60.2 | = 0.6 | | LDL-cholesterolmg/dl (mean ± SD) | 132.2 ± 47.1 | 125.3 ± 11.4 | = 0.2 | | Triglycerides mg/dl (mean ± SD) | 129.8 ± 46.2 | 127.8 ± 59.1 | = 0.8 | | HDL mg/dl (mean ± SD) | 45.6 ± 13.04 | 45.6 14.04 | = 0.7 | | Fractalkine pg/ml (mean ± SD) | 631.03 ± 144.2 | 254.3 ± 33.7 | = 0.0001 | | hsCRP mg/l (mean ± SD) | 114.3 ± 31.3 | 71.9 ± 16.2 | = 0.0001 |
|
|
Data were expressed as mean ± SD. SD: standard deviation.
|
